Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Dexmedetomidine as rescue drug during awake craniotomy for cortical motor mapping and tumor resection.

Moore TA, Markert JM, Knowlton RC

Department of Anesthesiology, University of Alabama School of Medicine, Birmingham, Alabama 35249-6810, USA. tamoore@uab.edu

Dexmedetomidine, approved for providing sedation in the critical care environment, is also used during awake craniotomies to facilitate procedures such as cortical mapping. Herein, we describe the use of dexmedetomidine as a rescue drug during awake craniotomy avoiding conversion to general anesthesia, thus allowing completion of cortical mapping.

Published 24 April 2006 in Anesth Analg, 102(5): 1556-8.
Full-text of this article is available online (may require subscription).

© 2004-2008 Brain Cancer Research Today. All Rights Reserved.